Condition: Uterine Fibroids (Leiomyoma) · Sponsor: Sheikh Shakhbout Medical City
The aim of this randomized controlled clinical trial is to evaluate the efficacy of green tea (EGCG) and vitamin D3 supplementation in preventing uterine fibroid recurrence following fibroid removal.
This description comes directly from the study's public registry record.
Tonianne J Grobmyer, Physician Associate · 800 · tonianne.grobmyer@ku.ac.ae
Leen Oyoun Alsoud, Master Pharmaceutical Sciences · +971 800 7762 · 100066957@ku.ac.ae
Always discuss trial participation with your own doctor first.
| Sheikh Shakbhout Medical City | Abu Dhabi, United Arab Emirates (uae), United Arab Emirates | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07647198